4.2 Article

Hemangioblast, hemogenic endothelium, and primitive versus definitive hematopoiesis

Journal

EXPERIMENTAL HEMATOLOGY
Volume 49, Issue -, Pages 19-24

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.exphem.2016.12.009

Keywords

-

Funding

  1. Medical Research Council
  2. Biotechnology and Biological Sciences Research Council
  3. Cancer Research UK
  4. BBSRC [BB/I001794/1] Funding Source: UKRI
  5. MRC [MR/P000673/1] Funding Source: UKRI
  6. Biotechnology and Biological Sciences Research Council [BB/I001794/1] Funding Source: researchfish
  7. Cancer Research UK [19565, 12486] Funding Source: researchfish
  8. Medical Research Council [MR/P000673/1] Funding Source: researchfish

Ask authors/readers for more resources

The types of progenitors generated during the successive stages of embryonic blood development are now fairly well characterized. The terminology used to describe these waves, however, can still be confusing. What is truly primitive? What is uniquely definitive? These questions become even more challenging to answer when blood progenitors are derived in vitro upon the differentiation of embryonic stem cells or induced pluripotent stem cells. Similarly, the cellular origin of these blood progenitors can be controversial. Are all blood cells, including the primitive wave, derived from hemogenic endothelium? Is the hemangioblast an in vitro artifact or is this mesoderm entity also present in the developing embryo? Here, we discuss the latest findings and propose some consensus relating to these controversial issues. (c) 2017 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available